ArticleJournal of clinical medicine2025

Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan.

Shoko Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.